Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2018-03-30 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
董事会关于募集资金2017年度存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report from the board of directors of 启迪古汉集团股份有限公司 regarding the use and management of funds raised in 2017 through a non-public stock issuance. It includes specifics on the amount raised, timing, usage, balances, management systems, regulatory compliance, and investment of idle funds. The document also contains an attachment with a detailed table comparing the use of raised funds against planned investments, project progress, and related notes. The content is focused on the company's capital raising activities and the subsequent use and management of those funds, which aligns with the definition of a Capital/Financing Update (CAP). The document is substantive, over 6,000 characters, and contains actual financial data and analysis related to fundraising and capital usage, not merely an announcement or certification. Therefore, the appropriate classification is CAP.
2018-03-30 Chinese
独立董事2017年度述职报告（安寿辉）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2017 Annual Work Report" and details the independent director's activities, attendance at board and shareholder meetings, opinions on various board resolutions, training, and oversight responsibilities during the 2017 fiscal year. It focuses on governance, supervisory roles, and compliance with laws and regulations, rather than presenting financial statements or audit results. The content is a detailed report on board/management activities and independent director duties, not a full annual report, audit report, or other financial filings. Therefore, it fits best under Board/Management Information (MANG). The document length is under 5,000 characters, but it is a substantive report, not a mere announcement or certification, so it is not RPA or RNS.
2018-03-30 Chinese
2017年度监事会工作报告
Management Reports Classification · 95% confidence The document is titled as the "2017年度监事会工作报告" which translates to "2017 Supervisory Board Work Report" of 启迪古汉集团股份有限公司. It details the supervisory board's activities throughout 2017, including meetings held, oversight of financial reports (2016 annual report, 2017 quarterly and half-year reports), internal controls, financial management, asset transactions, and compliance with laws and regulations. The document includes opinions on the company's operations and financial management, and references an audit report by an accounting firm. The content is a comprehensive report on the supervisory board's work and oversight for the year 2017, which aligns with a Management Report (MDA) rather than a full Annual Report (10-K) or Audit Report (AR). It is not a brief announcement or a certification, but a detailed narrative report on management oversight and company governance for the year. Therefore, the best fitting category is Management Reports (MDA). The document length (4402 characters) is sufficient for a detailed report and it contains substantive content rather than just announcements or certifications.
2018-03-30 Chinese
2017年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Evaluation Report" for the year 2017 by 启迪古汉集团股份有限公司. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2017, including detailed descriptions of internal control scope, standards, and findings. The content is comprehensive and includes detailed explanations of internal control policies, organizational structure, risk areas, and defect classifications. It is not a general annual report but a specific report focused on internal control evaluation. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and internal control evaluation results. The document length (8459 characters) and detailed content confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2017
2018-03-30 Chinese
非经营性资金占用及其他关联资金往来情况的专项说明
Audit Report / Information Classification · 95% confidence The document is a special explanation regarding non-operating fund occupation and other related party fund transactions for the year 2017 by 启迪古汉集团股份有限公司. It references audited financial statements for the year ended December 31, 2017, and includes a summary table of related party fund transactions. The document includes an auditor's review and opinion but is not the full audit report itself. It is a regulatory disclosure related to compliance with Chinese securities regulatory requirements about related party transactions and fund occupation. The document length is short (1724 characters), and it does not contain full financial statements or comprehensive audit details, but rather a specific disclosure and auditor's review statement. Therefore, it fits best under Audit Report / Information (AR) as it is a standalone audit-related disclosure and review of specific financial information related to audit compliance, not a full annual report or other category. FY 2017
2018-03-30 Chinese
第八届监事会第二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of a company regarding the approval of various reports related to the fiscal year 2017, including the Supervisory Board Work Report, the Annual Report, the Financial Final Accounts Report, the Profit Distribution Plan, the Internal Control Evaluation Report, and a Special Report on the Use of Raised Funds. The document states that these reports were reviewed and approved by the Supervisory Board and that some of these items still require shareholder meeting approval. The document itself does not contain the full reports but rather announces the resolutions and approvals of these reports. The document length is short (1665 characters) and it is an announcement of meeting resolutions rather than the reports themselves. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and meeting resolution notice, not as the full Annual Report or other detailed reports.
2018-03-30 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.